Literature DB >> 23912593

Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status.

Salvador Naranjo-Suarez1, Bradley A Carlson, Ryuta Tobe, Min-Hyuk Yoo, Petra A Tsuji, Vadim N Gladyshev, Dolph L Hatfield.   

Abstract

Under hypoxic conditions, cells activate a transcriptional response mainly driven by hypoxia-inducible factors (HIFs). HIF-1α stabilization and activity are known to be regulated by thioredoxin 1 (Txn1), but how the thioredoxin system regulates the hypoxic response is unknown. By examining the effects of Txn1 overexpression on HIF-1α function in HeLa, HT-29, MCF-7 and EMT6 cell lines, we found that this oxidoreductase did not stabilize HIF-1α, yet could increase its activity. These effects were dependent on the redox function of Txn1. However, Txn1 deficiency did not affect HIF-1α hypoxic-stabilization and activity, and overexpression of thioredoxin reductase 1 (TR1), the natural Txn1 reductase, had no influence on HIF-1α activity. Moreover, overexpression of Txn1 in TR1 deficient HeLa and EMT6 cells was still able to increase HIF-1α hypoxic activity. These results indicate that Txn1 is not essential for HIF-1α hypoxic stabilization or activity, that its overexpression can increase HIF-1α hypoxic activity, and that this effect is observed regardless of TR1 status. Thus, regulation of HIF-1α by the thioredoxin system depends on the specific levels of this system's major components.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23912593      PMCID: PMC3887957          DOI: 10.1007/s10059-013-0121-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  40 in total

1.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain.

Authors:  E C Vaux; E Metzen; K M Yeates; P J Ratcliffe
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

3.  Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch.

Authors:  David Lando; Daniel J Peet; Dean A Whelan; Jeffrey J Gorman; Murray L Whitelaw
Journal:  Science       Date:  2002-02-01       Impact factor: 47.728

4.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

5.  c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription.

Authors:  Arántzazu Alfranca; M Dolores Gutiérrez; Alicia Vara; Julián Aragonés; Felipe Vidal; Manuel O Landázuri
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

6.  Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension.

Authors:  Miguel Alvarez-Tejado; Arántzazu Alfranca; Julian Aragonés; Alicia Vara; Manuel O Landázuri; Luis del Peso
Journal:  J Biol Chem       Date:  2002-01-28       Impact factor: 5.157

7.  The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

Authors:  A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2001-10-16       Impact factor: 11.025

8.  The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.

Authors:  Sarah J Welsh; William T Bellamy; Margaret M Briehl; Garth Powis
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

9.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

Authors:  David Lando; Daniel J Peet; Jeffrey J Gorman; Dean A Whelan; Murray L Whitelaw; Richard K Bruick
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

10.  H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

Authors:  M Meyer; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  11 in total

Review 1.  Redox Paradox: A Novel Approach to Therapeutics-Resistant Cancer.

Authors:  Luksana Chaiswing; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2018-02-21       Impact factor: 8.401

Review 2.  Prospect of thioredoxin as a possibly effective tool to combat OSAHS.

Authors:  Ye Pan; You Lu; Jie-Dong Zhou; Cui-Xue Wang; Jin-Quan Wang; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Sleep Breath       Date:  2022-05-27       Impact factor: 2.816

3.  TXNDC2 joint molecular marker is associated with testis pathology and is an accurate predictor of sperm retrieval.

Authors:  Seyed-Morteza Javadirad; Mohammad Mokhtari
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

4.  Combating trastuzumab resistance by targeting thioredoxin-1/PTEN interaction.

Authors:  Akram Sadeghirizi; Razieh Yazdanparast; Safiyeh Aghazadeh
Journal:  Tumour Biol       Date:  2015-12-10

Review 5.  Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories.

Authors:  Anthony R Martin; Cyril Ronco; Luc Demange; Rachid Benhida
Journal:  Medchemcomm       Date:  2016-10-19       Impact factor: 3.597

6.  Txnip C247S mutation protects the heart against acute myocardial infarction.

Authors:  Yoshinobu Nakayama; Nobuhiro Mukai; Bing F Wang; Kristen Yang; Parth Patwari; Richard N Kitsis; Jun Yoshioka
Journal:  J Mol Cell Cardiol       Date:  2021-02-27       Impact factor: 5.763

7.  Repeated Superovulation via PMSG/hCG Administration Induces 2-Cys Peroxiredoxins Expression and Overoxidation in the Reproductive Tracts of Female Mice.

Authors:  Sun-Ji Park; Tae-Shin Kim; Jin-Man Kim; Kyu-Tae Chang; Hyun-Shik Lee; Dong-Seok Lee
Journal:  Mol Cells       Date:  2015-10-19       Impact factor: 5.034

8.  Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation.

Authors:  Clive Metcalfe; Anjana Ramasubramoni; Giordano Pula; Matthew T Harper; Stuart J Mundell; Carmen H Coxon
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

Review 9.  Thioredoxin-dependent system. Application of inhibitors.

Authors:  Anna Jastrząb; Elżbieta Skrzydlewska
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

10.  Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.

Authors:  Anqi Yao; Sarah J Storr; Khaled Al-Hadyan; Ruman Rahman; Stuart Smith; Richard Grundy; Simon Paine; Stewart G Martin
Journal:  Mol Neurobiol       Date:  2020-05-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.